Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis [Phase 4]
A Phase 4 trial comparing methotrexate combined with statins versus methotrexate alone in rheumatoid arthritis has completed.
-
FDA approval · 2019-11-22FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
FDA approved a supplemental application for Naproxen Sodium from CVS under ANDA 091353, resulting in updated approval for the product.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating Sunpharma1505 versus Reference1505 in active rheumatoid arthritis was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) [Phase 2]
Phase 2 pharmacokinetic/pharmacodynamic study comparing PF-05280586 to rituximab in rheumatoid arthritis patients with inadequate response t…
-
FDA approval · 2019-11-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic Naproxen product from Hikma Pharmaceuticals USA Inc. This action expands access to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-15FDA Approved: PREDNISONE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approves ANI Pharmaceuticals' original (generic) application for prednisone, enabling a generic prednisone product to be marketed.
-
FDA approval · 2019-11-14FDA Approved: CELECOXIB — Original Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's original application for a generic version of celecoxib (Celecoxib).
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging [Phase 1]
Phase 1 clinical trial evaluating Tc-99m tilmanocept localization in active rheumatoid arthritis subjects using SPECT and SPECT/CT imaging; …
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Tocilizumab REMission in Early RA [Phase 4]
A Phase 4 clinical trial update on tocilizumab in early rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Rosuvastatin in Rheumatoid Arthritis (RORA) [Phase 2, Phase 3]
Clinical trial update for rosuvastatin in rheumatoid arthritis across Phase 2 and Phase 3, indicating completion.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial assessing safety, tolerability, PK/PD, and efficacy of repeat dosing of GSK2982772 in moderate to severe rheumatoid arthritis;…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) [Phase 4]
Phase 4 trial update on etanercept and methotrexate in early arthritis aiming to induce remission.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) [Phase 4]
Phase 4 trial update for infliximab as induction therapy in early rheumatoid arthritis has completed enrollment and study completion status.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Targeted Ultrasound in Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update on targeted ultrasound as a monitoring/assessment tool for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial comparing etoricoxib with aceclofenac in patients with rheumatoid arthritis has completed.
-
FDA approval · 2019-10-26FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., resulting in an approved modification to the product’s lab…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab [Phase 3]
Phase 3 clinical trial evaluating ABP 798 versus rituximab in moderate to severe rheumatoid arthritis has completed with posted results in 2…
-
FDA approval · 2019-10-22FDA Approved: MELOXICAM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Meloxicam from Unichem Pharmaceuticals (USA), Inc. under ANDA 077927.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
A completed clinical trial comparing outcomes of rheumatoid arthritis patients starting Xeljanz with oral methotrexate who withdraw MTX vers…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis [Phase 1, Phase 2]
Clinical trial update for BMS-986251 (oral) in healthy participants and patients with psoriasis and rheumatoid arthritis; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs [Phase 2, Phase 3]
A clinical trial comparing upadacitinib to placebo in adults with rheumatoid arthritis who are on csDMARDs and have inadequate response to c…
-
FDA approval · 2019-10-17FDA Approved: PIROXICAM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for PIROXICAM from Unichem Pharmaceuticals (USA), Inc. (a generic piroxicam product).
-
FDA approval · 2019-10-09FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Celecoxib submitted by Actavis Pharma, Inc.